Skip to main content
. 2020 Jan 10;22(6):636–641. doi: 10.4103/aja.aja_135_19

Table 1.

Clinical characteristics of men with erectile dysfunction and normal erectile function (controls)

Characteristics Organic ED (n=74) Psychogenic ED (n=69) Control (n=52)
Age (year) 30.5±7.0 30.2±6.4 29.9±7.9
Course (month) 25.7±24.6 20.3±24.9 -
IIEF-5 score 10.0±4.2 11.5±5.1 -
PHQ-9 score 9.2±5.8 8.32±5.2 -
GAD-7 score 7.8±5.7 6.37±4.4 -
Height (m) 1.7±0.1 1.73±0 1.7±0.1
Weight (kg) 71.6±11.8 72.6±11.4 70.1±8.7
BMI (kg m−2) 23.9±3.1 24.8±3.8 23.9±2.6
TT (ng l−1) 5.0±1.4 4.7±1.4 4.3±1.1
CFT (pmol l−1) 332.4±96.3 308.4±82.8 297.1±4.9
BAT (ng ml−1) 2.5±0.7 2.3±0.5 2.1±0.4
E2 (pg ml−1) 36.9±10.2# 25.5±8.7 22.8±8.6
E2/TT (pg ng−1) 7.7±3.1# 6.3±2.9 4.9±2.0
PRL (ng ml−1) 16.5±7.3 16.7±8.4 15.9±4.0
LH (mIU ml−1) 5.3±2.0 5.1±2.0 4.6±1.2
FSH (mIU ml−1) 3.8±2.2 4.2±1.8 3.9±1.7
SHBG (nmol l−1) 34.8±12.9 36.9±16.0 34.4±16.8
ALB (g l−1) 44.9±2.7 45.5±3.3 49.2±2.8
MAPR (tip) (%) 49.7±10.0* 67.0±5.7 -
MAPR (base) (%) 58.1±13.8* 71.6±6.6 -
PTUM (tip) (%) 33.5±11.2* 38.6±13.4 -
PTUM (base) (%) 35.7±9.7* 40.1±10.8 -
Erection duration (min) 24.0±15.6 25.3±13.0 -

Data are presented as mean±s.d. #P<0.05, organic ED group compared with psychogenic ED group and control group; *P<0.05, organic ED group compared with psychogenic ED group. IIEF-5: International Index of Erectile Function 5 questionnaire; PHQ-9: patient health questionnaire; GAD-7: generalized anxiety disorder scale; BMI: body mass index; TT: total testosterone; CFT: calculated free testosterone; BAT: bioactive testosterone; E2: estradiol; E2/TT: estradiol to total testosterone ratio; PRL: prolactin; LH: luteinizing hormone; FSH: follicle-stimulating hormone; SHBG: sex hormone-binding globulin; ALB: albumin; MAPR: maximal average penile rigidity; PTUM: penile tumescence; -: no data was detected. s.d.: standard deviation; ED: erectile dysfunction